产品编号 | 产品名称 | 产品简述 | 应用领域 | 参考文献 | 客户反馈 |
Selisistat (EX 527) | Selisistat (EX 527)是一种特异性Sirtuin-1抑制剂,用于Huntington's的II期临床试验。 |
亨廷顿舞蹈症 |
Vertex Pharmaceuticals Incorporated. 2016 [1] Velásquez DA, et al. Diabetes, 2011, 60(4), 1177-1185. [2] Tao YF, et al. Transplant Proc, 2015, 47(6), 2003-2009. [3] Beier UH, et al. Mol Cell Biol, 2011, 31(5), 1022-1029. |
||
SRT1720 | SRT1720是一种选择性SIRT1激活剂 |
[1] Yu L, et al. Toxicol Lett, 2016, 64, 1-11. [2] Hansen LW, et al. Shock, 2016, 45(4), 359-366. [3] Kemelo MK, et al. Eur Rev Med Pharmacol Sci, 2016, 20(2), 363-371. [4] Chen YX, et al. Biochem Biophys Res Commun, 2015, 465(4), 732-738. |